Linked Data API

Show Search Form

Search Results

1727976
registered interest false more like this
date less than 2024-09-09more like thismore than 2024-09-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Pregnancy: Folic Acid more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the need for an educational campaign to highlight the importance of taking folic acid supplements while pregnant to reduce the chances of brain and spinal conditions in foetuses. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL900 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-16more like thismore than 2024-09-16
answer text <p>The Government and the devolved administrations recommend that women who could become pregnant, or plan to become pregnant, should take a daily supplement of 400 micrograms of folic acid before conception and up until the 12th week of pregnancy. This is in addition to any folic acid consumed through their diet.</p><p>In England, Start for Life provides information and support to pregnant women and expectant parents on the importance of taking folic acid on their website, and through an email programme. Public health messaging by health departments across the United Kingdom raises awareness of the importance of folic acid supplementation by women who may become pregnant, and for the first 12 weeks of pregnancy. The Government keeps the need for educational campaigns under review.</p><p>The Government monitors folate intake and status through the<em> National Diet and Nutrition Survey</em> (NDNS). The latest publication reported that 89% of women of childbearing age had increased risk of neural tube defects. New NDNS data, including folate status, is due to be published in early 2025.</p>
answering member printed Baroness Merron more like this
question first answered
less than 2024-09-16T15:25:42.997Zmore like thismore than 2024-09-16T15:25:42.997Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1727979
registered interest false more like this
date less than 2024-09-09more like thismore than 2024-09-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Influenza: Vaccination more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government, further to paragraph 4.5.6 of the NHS Vaccination Strategy, published on 13 December 2023, what is their timeline for the development of a cost-benefit analysis on the centralised procurement and supply of adult flu vaccines. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL903 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-16more like thismore than 2024-09-16
answer text <p>The NHS Vaccination Strategy outlined the intention to explore whether centralising the procurement and supply of adult flu vaccines could deliver better outcomes and address the existing clinical, operational, and financial challenges associated with local procurement. NHS England, the Department, and the UK Health Security Agency are working in partnership to plan a programme of work to consider this. This will include undertaking a cost-benefit analysis and market engagement with stakeholders. These plans, which include timelines, are still under development and subject to ministerial decision-making, but any potential changes as a result of this exploratory exercise will not be implemented before the 2026/27 financial year.</p> more like this
answering member printed Baroness Merron more like this
grouped question UIN HL904 more like this
question first answered
less than 2024-09-16T15:34:23.233Zmore like thismore than 2024-09-16T15:34:23.233Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1727980
registered interest false more like this
date less than 2024-09-09more like thismore than 2024-09-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Influenza: Vaccination more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government, further to paragraph 4.5.6 of the NHS Vaccination Strategy, published on 13 December 2023, what plans they have to engage with external stakeholders in the development of a cost-benefit analysis of the centralised procurement and supply of adult flu vaccines. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL904 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-16more like thismore than 2024-09-16
answer text <p>The NHS Vaccination Strategy outlined the intention to explore whether centralising the procurement and supply of adult flu vaccines could deliver better outcomes and address the existing clinical, operational, and financial challenges associated with local procurement. NHS England, the Department, and the UK Health Security Agency are working in partnership to plan a programme of work to consider this. This will include undertaking a cost-benefit analysis and market engagement with stakeholders. These plans, which include timelines, are still under development and subject to ministerial decision-making, but any potential changes as a result of this exploratory exercise will not be implemented before the 2026/27 financial year.</p> more like this
answering member printed Baroness Merron more like this
grouped question UIN HL903 more like this
question first answered
less than 2024-09-16T15:34:23.263Zmore like thismore than 2024-09-16T15:34:23.263Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1727482
registered interest false more like this
date less than 2024-09-04more like thismore than 2024-09-04
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Autism: Diagnosis more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what plans they have to improve (1) the diagnosis of autism, and (2) support for those who are assessed as having autism. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL759 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-12more like thismore than 2024-09-12
answer text <p>The Department is currently considering the next steps to improving diagnostic assessment and support for autistic people. It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including autism assessment and support services, in line with National Institute for Health and Care Excellence guidelines.</p><p>On 5 April 2023, NHS England published a national framework and operational guidance to deliver improved outcomes in all-age autism assessment pathways. This guidance will help ICBs and the National Health Service to deliver improved outcomes for children, young people, and adults referred to an autism assessment service. The guidance also sets out what support should be available before an assessment, and what support should follow a recent diagnosis of autism, based on the available evidence.</p><p>In 2024/25, £4.3 million is available nationally to improve services for autistic children and young people, including autism assessment services.</p>
answering member printed Baroness Merron more like this
question first answered
less than 2024-09-12T16:35:56.247Zmore like thismore than 2024-09-12T16:35:56.247Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1727206
registered interest false more like this
date less than 2024-09-03more like thismore than 2024-09-03
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Vaccination more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government when they intend to respond to the outstanding Joint Committee on Vaccination and Immunisation recommendations in relation to the approval and commissioning of new vaccines. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL725 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-10more like thismore than 2024-09-10
answer text <p>Officials across the Department, the UK Health Security Agency, and NHS England routinely develop policy options based on the advice issued by the Joint Committee on Vaccination and Immunisation (JCVI).</p><p>Officials must consider a number of factors before a policy position can be established, and the time taken to complete this process can vary depending on these factors, and the nature of the JCVI’s advice. It is important to fully consider feasibility and all operational and clinical factors to maintain the high standards of the United Kingdom’s world-leading vaccination programmes, and ensure best value for money for taxpayers.</p><p>The Department aims to respond rapidly to the JCVI’s advice, as demonstrated by the recent introduction of programmes to protect older adults and infants, through maternal vaccination, from the respiratory syncytial virus.</p> more like this
answering member printed Baroness Merron more like this
question first answered
less than 2024-09-10T16:01:56.14Zmore like thismore than 2024-09-10T16:01:56.14Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1727208
registered interest false more like this
date less than 2024-09-03more like thismore than 2024-09-03
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Breast Cancer: Statistics more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the quality and consistency of triple negative breast cancer data collected in England; and what steps they are taking to improve it. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL727 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-19more like thismore than 2024-09-19
answer text <p>Data on triple negative breast cancer for England is collected through the National Disease Registration Service (NDRS). An NDRS Quality Assurance Team is in place to identify, investigate, and monitor data quality issues, with over 130 Quality Assurance reports being run each month as well as quarterly reports to assess the completeness of key data.</p><p>To drive up the completeness of the data for triple negative breast cancer, progesterone receptor status, human epidermal growth factor receptor in situ hybridization status, and oestrogen receptor status are part of the Cancer Outcomes and Services Data set, which supports national registration.</p> more like this
answering member printed Baroness Merron more like this
question first answered
less than 2024-09-19T13:18:13.777Zmore like thismore than 2024-09-19T13:18:13.777Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1726505
registered interest false more like this
date less than 2024-09-02more like thismore than 2024-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Influenza: Vaccination more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what timelines are in place for the development of a cost-benefit analysis on the centralised procurement and supply of adult flu vaccines, in line with paragraph 4.5.6 of the NHS Vaccination Strategy. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL680 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-10more like thismore than 2024-09-10
answer text <p>The<em> NHS Vaccination Strategy</em> outlined the intention to explore whether centralising the procurement and supply of adult flu vaccines could deliver better outcomes and address the existing clinical, operational, and financial challenges associated with local procurement. NHS England, the Department, and the UK Health Security Agency are working in partnership on a programme of work to consider this. This will include undertaking a cost-benefit analysis and market engagement with stakeholders. The work, including timelines, is still under development and subject to ministerial decision-making.</p> more like this
answering member printed Baroness Merron more like this
grouped question UIN HL681 more like this
question first answered
less than 2024-09-10T11:13:24.47Zmore like thismore than 2024-09-10T11:13:24.47Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1726506
registered interest false more like this
date less than 2024-09-02more like thismore than 2024-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Influenza: Vaccination more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what plans they have to engage with external stakeholders in the development of a cost-benefit analysis of the centralised procurement and supply of adult flu vaccines, in line with paragraph 4.5.6 of the NHS Vaccination Strategy. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL681 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-10more like thismore than 2024-09-10
answer text <p>The<em> NHS Vaccination Strategy</em> outlined the intention to explore whether centralising the procurement and supply of adult flu vaccines could deliver better outcomes and address the existing clinical, operational, and financial challenges associated with local procurement. NHS England, the Department, and the UK Health Security Agency are working in partnership on a programme of work to consider this. This will include undertaking a cost-benefit analysis and market engagement with stakeholders. The work, including timelines, is still under development and subject to ministerial decision-making.</p> more like this
answering member printed Baroness Merron more like this
grouped question UIN HL680 more like this
question first answered
less than 2024-09-10T11:13:24.503Zmore like thismore than 2024-09-10T11:13:24.503Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1726563
registered interest false more like this
date less than 2024-09-02more like thismore than 2024-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hospitals: Surveys more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what is their assessment of the annual survey of hospital inpatients in England and Wales, published by the Care Quality Commission on 21 August. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL685 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-09-09more like thismore than 2024-09-09
answer text <p>The Care Quality Commission’s <em>Adult Inpatient Survey 2023 </em>shows high levels of trust in doctors and nurses. The fact that the vast majority of patients felt that they were treated with respect and dignity is a testament to the efforts of National Health Service staff. The results reveal a significant decline in experiences of accessing inpatient care, with worsening waiting lists, and too many patients saying that their health deteriorated while waiting for admission. The survey results add to the Government’s existing concerns about the state of the NHS.</p><p>Improving the NHS is a Government priority, but it will take time. My Rt hon. Friend, the Secretary of State for Health and Social Care has appointed Lord Darzi to lead the independent investigation of the NHS. It has a particular focus on assessing patient access to healthcare, the quality of healthcare being provided, and the overall performance of the health system. Baron Darzi will report this month.</p> more like this
answering member printed Baroness Merron more like this
question first answered
less than 2024-09-09T16:49:18.223Zmore like thismore than 2024-09-09T16:49:18.223Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1723969
registered interest false more like this
date less than 2024-07-29more like thismore than 2024-07-29
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Respiratory Syncytial Virus: Vaccination more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the expected coverage rates of maternal respiratory syncytial virus vaccination in the first year of the programme. more like this
tabling member printed
Baroness Ritchie of Downpatrick remove filter
uin HL443 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-08-06more like thismore than 2024-08-06
answer text <p>The Joint Committee on Vaccination and Immunisation considered uptake when developing their advice on a maternal respiratory syncytial virus (RSV) vaccination programme. Uptake for the RSV vaccination programme is expected to be like that of other year-round maternal respiratory immunisation programmes.</p> more like this
answering member printed Baroness Merron more like this
question first answered
less than 2024-08-06T08:24:41.58Zmore like thismore than 2024-08-06T08:24:41.58Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this